COVID-19 testing has been at the forefront in battling the pandemic. However, as the pandemic recedes and becomes more endemic, what will happen to the ever-changing COVID-19 testing market? Kalorama Information answers this question and more in COVID-19 Testing Markets, 2023.
The pandemic has been a learning curve for all parties to invest in diagnostic systems, as COVID-19 aptly pointed out. Notably, the pandemic reinforced the importance of testing and a significant number of companies are increasing their development of a wide selection of diagnostic tests in all markets. Diagnostics have been critical in the response to COVID-19.
This report provides market sizing and estimates for COVID-19 tests with discussion of market impacts of COVID-19.
Some of the key topics and trends explored include:
At-Home Testing
Insurance Coverage
Multiplex Testing
Expiration of Public Health Emergency
New Variants on the Horizon
Immunoassay Testing
Molecular Testing
Global Regional Analysis
The report’s global analysis features research, such as 2022-2027 sales estimates and forecasts, for regions and countries including:
APAC
Europe
North America
Rest of World
Australia
Austria
Belgium
Brazil
Canada
China
Denmark
France
Germany
India
Italy
Mexico
Netherlands
Japan
Poland
Romania
South Africa
Spain
Sweden
Switzerland
Turkey
United Kingdom
United States
Competitive Analysis
The report includes analysis and profiles of key companies competing in this industry, including a breakout of the top competitors in the COVID-19 testing market based on 2022 manufacturer revenues.
Companies profiled include:
Abbott
Access Bio, Inc
Becton-Dickinson
BioMérieux
Bio-Rad
Cue Health
Danaher corporation
Diasorin
ELITechGroup
Genedrive plc
Hologic
LumiraDx UK
OraSure Technologies
PerkinElmer, Inc
Qiagen
QuantuMDx
QuidelOrtho
Roche Diagnostic Corporation
Seegene
Siemens Healthineers
Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co)
Thermo Fisher Scientific
Scope and Methodology
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews, in-person interviews and email correspondence were the primary methods of gathering information. For the purpose of this study, Kalorama Information conducted interviews with industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests. The base year for data was 2022. Data are provided for 2022 and 2027 with compound annual growth rates (CAGRs) for 2022 and 2027. Competitive analysis is provided for the top ten participants in the market. Regional breakdowns are surveyed for North America, Europe, Asia-Pacific and Rest of World. The forecasted market analysis through 2027 was largely based on demographic trends, new developments, trajectory of COVID-19 and its variants, innovative technology and global use.
Executive Summary
Industry at a Glance
Scope and Methodology
Size and Growth of the Market
Table Global COVID-19 Testing (Immunoassay, Molecular, Rapid) Sales by Segment, 2022-2027
Table Global COVID-19 Market by Key Segment (Molecular, Immunoassay), 2020-2027
Key Issues and Trends Affecting the Market
Competitive Outlook
Conclusion Highlights
Introduction
Overview
Table Coronavirus (COVID-19) 7-Day Case Snapshot Global by Country
Table Coronavirus (COVID-19) Situation by WHO Region (Africa, Americas, Eastern Mediterranean, Europe, South-East Asia, West Pacific)
Table Coronavirus (COVID-19) Cumulative Cases and 7-Day Cases by WHO Region (Africa, Americas, Eastern Mediterranean, Europe, South-East Asia, West Pacific)
Table Country-Level COVID-19 Cumulative Cases, by Country (Australia, Brazil, Canada, France, Germany, India, Indonesia, Italy, Japan, Mexico, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom, United States, Vietnam), Through April 11, 2023
Table Country-Level COVID-19 Cumulative Diagnostic Tests Administered, by Country (Australia, Brazil, Canada, France, Germany, India, Indonesia, Italy, Japan, Mexico, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom, United States, Vietnam), Through April 11, 2023
Table New Cases vs. Total Cases for Select Countries with Uptick in Cases, by Country (Afghanistan, Austria, Czechia, Hong Kong, Indonesia, Japan, Mexico, Pakistan, Philippines, Poland, Russia, Saudi Arabia, South Korea, Vietnam), April 2023
Issues and Trends
At-Home Testing
Table At-Home COVID-19 Test Distribution of Sales, by Vendor (Abbott Diagnostics, Becton Dickinson, OraSure Technologies, Quidel, Siemens Healthineers, Others)
Insurance Coverage
Multiplex Testing
EUAs and Public Health Emergency Expiration
New Variants On the Horizon
COVID-19 Immunoassay Testing
Overview
Enzyme-linked Immunosorbent Assay (ELISA)
Mass Spectrometry
Rapid
Products
Antigen
Table Selected Antigen Immunoassay Tests for SARS-CoV-2
Antibody
Table Selected Antibody Immunoassay EUA Tests for COVID-19
Market Size and Growth
Table Global Immunoassay COVID-19 Testing Market, 2022-2027 $MN; CAGR 2022-2027
Table Estimated Global Immunoassay COVID-19 Testing Market Distribution by Segment (Antigen, Serology) and End User (Laboratory, Rapid/Near Patient), 2022, (%)
Table Global COVID-19 Testing (Immunoassay, Molecular, Rapid) Sales, by Segment, 2022-2027 ($MN)
Table Global IVD Market (COVID-19 Assays and Instruments, Excluding COVID-19 Assays and Instruments), 2019-2022, ($MN)
Table Global IVD Market, Distribution by Performance Segment (COVID-19 Assays and Instruments, Excluding COVID-19 Assays and Instruments), 2022 (%)
Market Segment by Test Type/Site
Table Global COVID-19 Testing by Test Site (Laboratory, Rapid/Near Patient) Sales by Segment, 2022- 2027
Table Global COVID-19 IVD Market by Test Site, 2020-2022 and Forecast Through 2027 ($MN)
Laboratory Based
Table Global Lab-based COVID-19 Testing Market, Distribution of Sales by Segment (Immunoassay, Molecular), 2022-2027 ($MN)
Point of Care
Table Global Rapid-based COVID-19 Testing Market, Distribution of Sales by Segment (Immunoassay, Molecular), 2022-2027 ($MN)
Table Global COVID-19 IVD Market by Test Method, 2020-2022 and Forecast Through 2027 ($MN)
Market by Region
Table Estimated Global COVID-19 Testing Market by Region (APAC, Europe, North America, Rest of World), 2020-2022
Table COVID-19 Testing Market by Country (Australia, Austria, Belgium, Brazil, Canada, China, Denmark, France, Germany, India, Italy, Mexico, Netherlands, Japan, Poland, Romania, South Africa, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States), Estimated 2022 ($M)
Competitive Analysis
Table Top 10 COVID-19 Vendors and Global Market Share, by Vendor (Abbott, bioMérieux, Danaher, Hologic, PerkinElmer, Qiagen, QuidelOrtho, Roche, Siemens, ThermoFisher, Others), 2022
Selected Market Participants
Abbott
Table Abbott Corporate Summary
Company Overview
COVID-19
Access Bio, Inc
Table Access Bio Corporate Summary
Company Overview
COVID-19
Becton-Dickinson
Table Becton-Dickinson Corporate Summary
Company Overview
COVID-19
bioMérieux
Table bioMérieux Corporate Summary
Company Overview
COVID-19
Bio-Rad
Table Corporate Summary
Company Overview
COVID-19
Cue Health
Table Cue Health Corporate Summary
Company Overview
COVID-19
Danaher Corporation
Table Danaher Corporate Summary
Company Overview
COVID-19
DiaSorin S.p.A.
Table DiaSorin Corporate Summary
Company Overview
COVID-19
ELITech Group S.A.S.
Table ELITech Group Corporate Summary
Company Overview
COVID-19
Genedrive plc
Table genedrive Corporate Summary
Company Overview
COVID-19
Hologic, Inc
Table Hologic Corporate Summary
Company Overview
COVID-19
LumiraDx UK Limited
Table LumiraDx Corporate Summary
Company Overview
COVID-19
OraSure Technologies, Inc.
Table OraSure Technologies Summary
Company Overview
COVID-19
PerkinElmer, Inc
Table PerkinElmer Corporate Summary
Company Overview
COVID-19
QIAGEN N.V.
Table QIAGEN Corporate Summary
Company Overview
COVID-19
QuantuMDx Group, Ltd.
Table QuantuMDx Corporate Summary
Company Overview
COVID-19
QuidelOrtho Corporation
Table QuidelOrtho Corporate Summary
Company Overview
COVID-19
Roche Diagnostic Corporation
Table Roche Diagnostic Corporate Summary
Company Overview
COVID-19
Seegene, Inc
Table Seegene Corporate Summary
Company Overview
COVID-19
Siemens Healthineers GmbH
Table Siemens Healthineers Corporate Summary
Company Overview
COVID-19
Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co)